According to Cytek Biosciences's latest financial reports the company has $0.26 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.26 B | -23.08% |
2022-12-31 | $0.34 B | -6.44% |
2021-12-31 | $0.36 B | 120.67% |
2020-12-31 | $0.16 B | 448.54% |
2019-12-31 | $30.12 M |